rottlerin and Skin-Neoplasms

Earlier studies demonstrated that Rottlerin exerts a time- and dose-dependent antiproliferative effect on SK-Mel-28 melanoma cells during 24 h of treatment, but cytotoxicity due to cell death began only after a 48 h exposure. In the current study, in order to identify the type of cell death in this cell line, which is notoriously refractory to most anticancer therapies, and to clarify the underlying mechanisms of this delayed outcome, we searched for apoptotic, necrotic/necroptotic and autophagic traits in Rottlerin-exposed cells. Although SK-Mel-28 cells are both apoptosis and autophagy competent, Western blotting analysis, caspase activity assay, nuclear imaging and the effects of autophagy, apoptosis and necroptosis inhibitors, indicated that Rottlerin cytotoxicity was due to none of the aforementioned death mechanisms. Nevertheless, in growth arrested cells, the death did occur after a prolonged treatment and most likely ensued from the observed blockage of protein synthesis that reached levels expected to be incompatible with cell survival. From a mechanistic point of view, we ascribed this effect to the documented inhibition of mTORC1 activity; mTORC1 inhibition on the one hand led to a not deadly, rather protective autophagic response but, on the other hand caused a near complete arrest of protein synthesis. Interestingly, no cytotoxicity was found towards normal skin fibroblasts, which only resulted mildly growth arrested by the drug.

Topics: Acetophenones; Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Autophagy; Benzopyrans; Cell Cycle Proteins; Cell Line; Dose-Response Relationship, Drug; Humans; Mechanistic Target of Rapamycin Complex 1; Melanoma; Multiprotein Complexes; Phosphoproteins; Protein Biosynthesis; Protein Kinase Inhibitors; Protein Synthesis Inhibitors; Signal Transduction; Skin Neoplasms; Time Factors; TOR Serine-Threonine Kinases